Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in Neuroblastoma
Authors:
- K. SahinKSK. Sahin
- F. BertholdFBF. Berthold
- B. HeroBHB. Hero
- H.-J. TerpeHTH.-J. Terpe
- F. LampertFLF. Lampert
- 1 January 1995
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 31 (4) , 541-544
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- CD44 -- A New Prognostic Marker for NeuroblastomaNew England Journal of Medicine, 1993
- P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for NeuroblastomaNew England Journal of Medicine, 1991
- A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 casesCancer, 1991
- Prognostic factors in Neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosisCancer, 1988
- Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastomaBritish Journal of Cancer, 1988
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Cellular DNA Content as a Predictor of Response to Chemotherapy in Infants with Unresectable NeuroblastomaNew England Journal of Medicine, 1984
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984
- Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumourNature, 1983
- Abnormalities of chromosome 1p in human neuroblastoma tumors and cell linesCancer Genetics and Cytogenetics, 1982